Alterola Biotech, Inc. (ABTI) Research

Alterola Biotech, Inc. is a pharmaceutical company dedicated to the research and development of cannabinoid and cannabinoid-like molecules. The firm primarily focuses on pioneering regulated pharmaceutical products for human and animal health, as well as regulated food items. Key activities also include the production of active pharmaceutical ingredients (APIs) and food-grade components. Furthermore, the company emphasizes drug formulation and advanced delivery systems to improve bioavailability, solubility, and overall stability. It operates out of Birkenhead, United Kingdom.

Market snapshot

Symbol
ABTI
Price
$0.01
Day change
0.00%
Market cap
$7.4M
P/E ratio
-2.67x
52-week range
0.0002-0.2
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Peer companies

  • Benchmark Holdings plc (BHCCF)
  • Craftport Cannabis Corp. (BHHKF)
  • Cellectis S.A. (CMVLF)
  • Cipher Pharmaceuticals Inc. (CPHRF)
  • 3-D Matrix, Ltd. (DMTRF)
  • Spectral Medical Inc. (EDTXF)
  • Integrated Diagnostics Holdings plc (IDGXF)
  • Mayne Pharma Group Limited (MAYNF)

Recent insider activity

  • Bright Green Corp — trade (0 shares) on 2022-10-03

Open Alterola Biotech, Inc. (ABTI) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.